![]() |
|
|
Forward to a colleague |
||
Product Overview A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here Access Full Stories Using technology recently licensed from Kreatech, Agilent has launched a kit to enable researchers to more easily access genetic information from formalin-fixed paraffin embedded (FFPE) samples... Read Private firms make attractive 'prey' Privately held lab equipment firms are increasingly 'prey for value hunters', according to a new analyst report from Plimsoll Publishing... Read Industry news in brief - week 33 LabTechnologist.com brings you its periodic round up of industry news, featuring developments at Amphion Innovations, Durham Scientific Crystals, Celsis, Biotage, and Malvern Instruments... Read Invitrogen takes the stress out of stem cell 'passaging' The launch of Invitrogen's Stempro EZPassage should substantially reduce the time and stress involved in dividing up cultures of human embryonic stem cell (hESC) colonies... Read First 3D images of living cell a 'dream' A US scientist says he has fulfilled his dream by creating the first 3D images of a living cell, finally allowing researchers to study them in their natural state... Read |
||||||||||||||
All News Headlines for: August | July | June |
||||||||||||||
![]() A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here |
||||||||||||||
|
Related Industry News Pfizer pipped to the post by biologics plant announcement Pfizer was taken by surprise this week as a US engineering firm announced that it had been awarded a contract to manage construction of the firm's proposed biotech production plant in Ireland, before the plant... Read Amgen admits job cuts on way after anaemia drugs debacle Amgen has finally put an end to weeks of rumours and speculations by admitting its plans to slash 12-14 per cent of its workforce to offset the recent difficulties it has been facing with the sales of its anaemia... Read Blockbuster potential for Actelion insomnia drug Analysts are waiting with baited breath for the latest clinical data on Actelion's first-in-class insomnia drug, pointing to its blockbuster potential and deriding current insomnia drugs as 'shockingly limited'... Read Did Pfizer overpay in Icagen deal? Pfizer has penned a discovery-stage deal with Icagen aimed at finding potential pain alleviating drugs, but has forked out over twice the industry average... Read
|
||||||||||||||
|
|||
Forward to a colleague |
|||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||